SEC Form 4 · accession 0001209191-17-018938
MAGELLAN HEALTH INC · MGLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey N West
Officer — SVP & Controller
Period of report
Mar 3, 2017
Accepted (ET)
Mar 7, 2017 · 5:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000019411
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Common Stock, $0.01 par valueF2 | Mar 3, 2017 | M | 1,097 | $0.00 | A | 12,472 | D | |
| Ordinary Common Stock, $0.01 par valueF4 | Mar 3, 2017 | F | 365 | $68.50 | D | 12,107 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2,F5 | $0.00 | Mar 3, 2017 | M | 1,097 | A | Mar 3, 2017 | — | Common Stock | 1,097 | 2,194 | D |
Explanation of responses
- F1This transaction was effectuated by a one-third vesting of the Restricted Stock Unit Award granted on March 3, 2016. Each Restricted Stock Unit represents a contingent right to receive one share of Magellan common stock.
- F2Not applicable.
- F3Represents the portion of shares withheld by the Company in order to pay taxes.
- F4Closing price on NASDAQ on March 3, 2017.
- F5The remainder of 2,194 Restricted Stock Units shall vest in equal increments on each of March 3 of 2018 and 2019.